Monoclonal antibody T-88
Alternative Names: T 88Latest Information Update: 24 Aug 2009
Price :
$50 *
At a glance
- Originator Chiron Corporation
- Class Immunotherapies; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gram-negative infections; Septic shock
Most Recent Events
- 20 Apr 1995 A study has been included in the therapeutic trials section